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INTRODUCTION
Hepatic pseudolymphoma, also known as reactive lymphoid hyperplasia or nodular lymphoid hyperplasia is a benign nodular lesion, histopathologically characterized by marked proliferation of non-neoplastic, polyclonal lymphocytes forming follicles with germinal centers (1, 2) . The lesion is encountered in various organs such as orbit, lung, skin, and gastrointestinal tract. However, the involvement of liver is extremely rare (3, 4) .
We describe a rare case of hepatic pseudolymphoma misdiagnosed as hepatocellular carcinoma (HCC) or neuroendocrine tumor (NET) metastasis that developed in a patient who had primary biliary cirrhosis (PBC) and a rectal NET and discuss the imaging features of CT, MRI, fluorodeoxyglucose (FDG) positron emission tomography (PET)/CT and intraoperative US.
CASE REPORT
A 75-year-old female with a history of PBC was referred to our hospital for the further evaluation and treatment of a rectal NET which had been detected and confirmed in an outside hospital. On admission, physical examination did not reveal any significant abnormalities. The laboratory tests revealed anemia Hepatic pseudolymphoma is a rare benign liver mass that is characterized by proliferation of non-neoplastic lymphocytes extranodally. To the best of our knowledge, only 46 cases have been reported in the English literature. We described the case of a 75-year-old woman with hepatic pseudolymphoma mimicking a hypervascular tumor. After the histological confirmation of the rectal neuroendocrine tumor, CT scan revealed a 1.0 cm-sized, poorly-defined and low-density nodule in the liver. On MRI, the hepatic nodule showed an arterial enhancement and a low-signal intensity on the hepatobiliary phase. On diffusion-weighted imaging, the hepatic nodule showed a high signal intensity on a high b-value. On fluorodeoxyglucose (FDG) positron emission tomography (PET)/CT, it revealed a high standardized uptake value nodule. The US showed the hypoechoic nodule and the US-guided biopsy confirmed the hepatic pseudolymphoma. The patient's abdominopelvic CT scan also showed a 1.0 cm in size, poorly-defined, slightly hypodense nodule in the liver segment 8 (Fig. 1A, B ), and PET/CT also showed a high standardized uptake value (max SUV: 4.2) at the liver, suggesting hypermetabolic nodule (Fig. 1C ). Upon additional diagnostic information, we performed a liver MRI (Ingenia 3.0T, Philips, Best, Netherlands) using gadoxetic acid (Gd-EOB-DTPA-Primovist ® ; Bayer-Schering, Berlin, Germany). The hepatic nodule showed a low-signal intensity on T1-weighted images (T1WI) and a high-signal intensity on T2-weighted images (T2WI).
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During the dynamic study, it showed homogeneous arterial en- coholic steatohepatitis) (2, 6) . It is speculated that a reactive immunological response to a chronic infection or inflammation is related to the etiology of pseudolymphoma. Our patient shows to have a history of PBC. More importantly, many of the reported cases had an accompanying malignancy. And she was also confirmed a moderately differentiated rectal NET. So the immunoreaction against the cancer cells might be related to the development of pseudolymphoma (2, 6, 7) .
It is difficult to make a definite diagnosis in most cases of hepatic pseudolymphoma based on imaging without a histopathological diagnosis. On US, most of the lesions are homogeneous hypoechoic or markedly hypoechoic nodules mimicking cysts (1, 4) . On CT, the nodules tend to show hypodensity on precontrast images, slightly early enhancement in the arterial phase, and hypo to isodensity in the equilibrium phase (1, 7). On
MRI, most of the lesions show low-signal intensity on T1WI,
high-signal intensity on T2WI, high-signal intensity on DWI and low-signal intensity on the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI (1, 7) . These radiologic findings are not specific in the discrimination of pseudolymphoma from other hepatic tumors. Especially, these findings are first cousins to those of HCC or hypervascular metastatic carcinoma, and most cases have been misdiagnosed as these based on image findings and clinical information (2, 6, 8) . Our patient also showed a markedly hypoechoic single nodule on the US and the hypodense single nodule on the CT. The hepatic nodule showed a high-signal intensity on arterial phase and low-signal intensity on the porto-venous phase, transitional phase and hepatobiliary phase on the MRI.
The differential diagnosis of hypoechoic liver mass includes malignant tumors such as HCC, metastases, lymphoma and rare benign tumors such as focal nodular hyperplasia (FNH), hepatic adenoma, and hemangioma (9) . When considering the MRI findings, FNH, hepatic adenoma and hemangioma could be excluded from the differential diagnosis. Besides the nodule showed a high-standardized uptake value on FDG PET-CT, the possibility of malignancy is more likely than that of benign tumor. Hepatic metastasis may show various echogenicity depending on the primary lesion. Dorffel and Wermke (10) reported that hepatic metastasis of a NET could show various echogenicity depending on their primary lesion. And they reported that it shows hypo-echogenicity or iso-echogenicity on the US if their primary organ is a colon. Thus, all of the mentioned findings were considered, we could not make an accurate diagnosis between metastatic NET and hepatic pseudolymphoma. A vessel-penetrating sign was also reported on CT during arterial portography, suggesting partial preservation of intra-tumoral portal tracts, which is not typical of HCC or metastatic tumors.
On a recent report, treatment methods of hepatic pseudolymphoma were recorded for 40 patients; resection in 32 cases (80%), liver transplantation in 3 cases, biopsy in 2 cases, ethanol injection in 1 case, autopsy in 1 case, and observation in 1 case (2) . Majority of the reported cases were treated with surgical resection due to uncertain diagnosis. Since generally this lesion occurs with pre-existing liver disease simultaneously, accurate diagnosis is important to avoid unnecessary transplants or surgical resection.
In conclusion, the accurate diagnosis of hepatic pseudolymphoma is difficult because of its nonspecific radiologic findings.
Nevertheless a single nodule is found in a patient with underlying chronic liver disease and malignancy, hepatic pseudolymphoma might be considered as a differential diagnosis to avoid unnecessary transplants or surgical resection. Although it is rare, knowledge of these recorded imaging findings will be helpful to radiologists when considering the possibility of hepatic pseudolymphoma as a differential diagnosis.
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